Nervous system | |||||
---|---|---|---|---|---|
Nervous system / Epilepsy and other seizure disorders | |||||
acetazolamide | On Formulary | ||||
Modified-release capsule | |||||
Diamox SR (Advanz Pharma) | On Formulary | ||||
Powder for solution for injection | |||||
Diamox (Advanz Pharma) | Hospital Only | ||||
brivaracetam | On Formulary | ||||
Oral solution | |||||
Briviact (UCB Pharma Ltd) | On Formulary | ||||
Solution for injection | |||||
Briviact (UCB Pharma Ltd) | On Formulary | ||||
cannabidiol | On Formulary |
NICE TA614 NICE TA615 NICE TA873 |
|||
Schedule 2 Controlled Drug
Schedule 2 Controlled Drug |
|||||
carbamazepine | On Formulary | ||||
Antiepileptic Adjustment Chart
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Modified-release tablet | |||||
Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
Oral suspension | |||||
Carbamazepine (Non-proprietary) | On Formulary | ||||
Tegretol (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
Suppository | |||||
Carbamazepine (Non-proprietary) | On Formulary | ||||
clobazam | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Difficult to Obtain Letter
|
|||||
Oral suspension | |||||
Clobazam (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Difficult to Obtain Letter
see attached |
|||||
Perizam (Rosemont Pharmaceuticals Ltd) | On Formulary | ||||
Zacco (Thame Laboratories Ltd) | On Formulary | ||||
clonazepam | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Difficult to Obtain Letter
|
|||||
Oral solution | |||||
Clonazepam (Non-proprietary) | On Formulary | ||||
ethosuximide | On Formulary | ||||
Antiepileptic Adjustment Chart
Antiepileptic Adjustment Chart |
|||||
Oral solution | |||||
Ethosuximide (Non-proprietary) | On Formulary | ||||
Antiepileptic Adjustment Chart
Antiepileptic adjustment chart |
|||||
fosphenytoin sodium | On Formulary | ||||
gabapentin | On Formulary | ||||
Barts Health Guidelines for Treating Acute Pain in Paediatric Patients
see attached |
|||||
Antiepileptic Adjustment Chart
Antiepileptic Adjustment Chart |
|||||
Oral solution | |||||
Gabapentin (Non-proprietary) | On Formulary | ||||
Barts Health Guidelines for Treating Acute Pain in Paediatric Patients
see attached |
|||||
Antiepileptic Adjustment Chart
Antiepileptic Adjustment Chart |
|||||
lacosamide | On Formulary | ||||
Antiepileptic Adjustment Chart
Antiepileptic Adjustment Chart |
|||||
lamotrigine | On Formulary | ||||
Antiepileptic Adjustment Chart
Antiepileptic Adjustment Chart |
|||||
levetiracetam | On Formulary | ||||
Oral solution | |||||
Levetiracetam (Non-proprietary) | On Formulary | ||||
Keppra (UCB Pharma Ltd) | On Formulary | ||||
Solution for infusion | |||||
Levetiracetam (Non-proprietary) | On Formulary | ||||
Keppra (UCB Pharma Ltd) | On Formulary | ||||
oxcarbazepine | On Formulary | ||||
Antiepileptic Adjustment Chart
|
|||||
perampanel | On Formulary | ||||
phenobarbital | On Formulary | ||||
Agreed standard strength - paediatrics
Phenobarbital 50mg/5ml alcohol free liquid should be used for all children 15mg/5ml should not be used in paediatrics (BP product contains exessive alcohol) |
|||||
Difficult to Obtain Letter
see attached |
|||||
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
phenytoin | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
NEONATAL FORMULARY VERSION 10
see attached |
|||||
Chewable tablet | |||||
Epanutin (Viatris UK Healthcare Ltd) | On Formulary | ||||
Oral suspension | |||||
Epanutin (Viatris UK Healthcare Ltd) | On Formulary | ||||
Solution for injection | |||||
Phenytoin (Non-proprietary) | Hospital Only | ||||
Parenteral preparations
Hospital use only |
|||||
Epanutin (Viatris UK Healthcare Ltd) | On Formulary | ||||
rufinamide | On Formulary | ||||
Oral suspension | |||||
Inovelon (Eisai Ltd) | On Formulary | ||||
sodium valproate | On Formulary | ||||
Management of Infantile Spasms and West Syndrome
Management of Infantile Spasms and West Syndrome June 2016 |
|||||
Antiepileptic Adjustment Chart
Antiepileptic Adjustment Chart |
|||||
Modified-release tablet | |||||
Epilim Chrono (Sanofi) | On Formulary | ||||
Epival CR (G.L. Pharma UK Ltd) | On Formulary | ||||
Gastro-resistant tablet | |||||
Sodium valproate (Non-proprietary) | On Formulary | ||||
Epilim (Sanofi) | On Formulary | ||||
Modified-release capsule | |||||
Episenta (Desitin Pharma Ltd) | On Formulary | ||||
Modified-release granules | |||||
Epilim Chronosphere MR (Sanofi) | On Formulary | ||||
Episenta (Desitin Pharma Ltd) | On Formulary | ||||
Oral solution | |||||
Sodium valproate (Non-proprietary) | On Formulary | ||||
Epilim (Sanofi) | On Formulary | ||||
Solution for injection | |||||
Sodium valproate (Non-proprietary) | On Formulary | ||||
Powder and solvent for solution for injection | |||||
Sodium valproate (Non-proprietary) | On Formulary | ||||
stiripentol | On Formulary | ||||
Stiripentol shared care guideline_March 2016
Stiripentol shared care guideline March 2016 |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
tiagabine | On Formulary | ||||
topiramate | On Formulary | ||||
Management of Infantile Spasms and West Syndrome
see attached |
|||||
Antiepileptic Adjustment Chart
see attached |
|||||
vigabatrin | On Formulary | ||||
Management of Infantile Spasms and West Syndrome
Management of Infantile Spasms and West Syndrome June 2016 |
|||||
Antiepileptic Adjustment Chart
Antiepileptic Adjustment Chart |
|||||
zonisamide | On Formulary | ||||
Management of Infantile Spasms and West Syndrome
Management of Infantile Spasms and West Syndrome June 2016 |
|||||
Nervous system / Status epilepticus | |||||
diazepam | On Formulary | ||||
Diazepam
Injection formulation is Hospital Only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
see attached |
|||||
fosphenytoin sodium | On Formulary | ||||
lorazepam | Hospital Only | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
LORAZEPAM
Injection Formulation is Hospital Use Only |
|||||
midazolam | On Formulary | ||||
NEONATAL FORMULARY VERSION 10
See attached |
|||||
Paediatric Premedication Guideline
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Buccal midazolam
For buccal midazolam doses less than 2.5mg Buccolam pre filled syringes cannot be used; use midazolam oromucosal solution 10mg/ml 4 dose pack (ie 5ml Bottle with 4 syringes pack; Epistatus brand; Unlicensed medicine) For all other doses Bucccolam (licensed) should be used |
|||||
oral midazolam solution
Oral Midazolam liquid is switching to 5mg/mL (Miprosed) This is for the ORAL SOLUTION only for use in oral sedation (not for buccal use) This product (a 7.5mL bottle) is for single use only and hence needs to be discarded after each use. |
|||||
Oral solution | |||||
Ozalin (Primex Pharmaceuticals Oy) | Off Formulary | ||||
Oromucosal solution | |||||
Buccolam (Neuraxpharm UK Ltd) | On Formulary | ||||
Midazolam Shared Care Guideline
Midazolam Shared Care Guideline |
|||||
Paediatric Premedication Guideline
Paediatric Premedication Guideline |
|||||
paraldehyde | On Formulary | ||||
NEONATAL FORMULARY VERSION 10
see atatcehd |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
phenytoin | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
NEONATAL FORMULARY VERSION 10
see attached |
|||||
Chewable tablet | |||||
Epanutin (Viatris UK Healthcare Ltd) | On Formulary | ||||
Oral suspension | |||||
Epanutin (Viatris UK Healthcare Ltd) | On Formulary | ||||
Solution for injection | |||||
Phenytoin (Non-proprietary) | Hospital Only | ||||
Parenteral preparations
Hospital use only |
|||||
Epanutin (Viatris UK Healthcare Ltd) | On Formulary | ||||
thiopental sodium | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH
|
|||||
THIOPENTAL SODIUM
Hospital Use Only |
|||||
Powder for solution for injection | |||||
Thiopental sodium (Non-proprietary) | On Formulary | ||||
Thiopental
Hospital Use Only |
|||||
Nervous system / Local anaesthesia | |||||
adrenaline with articaine hydrochloride | Hospital Only | ||||
Solution for injection | |||||
Septanest (Septodont Ltd) | Hospital Only | ||||
bupivacaine hydrochloride | Hospital Only | ||||
BUPIVACAINE HYDROCHLORIDE
Hospital Use Only |
|||||
Solution for injection | |||||
Bupivacaine hydrochloride (Non-proprietary) | On Formulary | ||||
BUPIVACAINE HYDROCHLORIDE
Hospital Use Only |
|||||
Infusion | |||||
Bupivacaine hydrochloride (Non-proprietary) | On Formulary | ||||
BUPIVACAINE HYDROCHLORIDE
Hospital Use Only |
|||||
bupivacaine with adrenaline | Hospital Only | ||||
Bupivacaine and Adrenaline
Hospital Use Only |
|||||
Solution for injection | |||||
Bupivacaine with adrenaline (Non-proprietary) | On Formulary | ||||
Bupivacaine and Adrenaline
Hospital Use Only |
|||||
levobupivacaine | On Formulary | ||||
LEVOBUPIVACAINE
Hospital Use Only |
|||||
Solution for injection | |||||
Chirocaine (AbbVie Ltd) | On Formulary | ||||
LEVOBUPIVACAINE
Hospital Use Only |
|||||
lidocaine hydrochloride | On Formulary | ||||
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Solution for injection | |||||
Lidocaine hydrochloride (Non-proprietary) | On Formulary | ||||
Ointment | |||||
Lidocaine hydrochloride (Non-proprietary) | On Formulary | ||||
Epistaxis in children
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
Spray | |||||
Xylocaine (Aspen Pharma Trading Ltd) | On Formulary | ||||
Epistaxis in children
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
lidocaine with adrenaline | On Formulary | ||||
Note:
Hospital only |
|||||
Solution for injection | |||||
Xylocaine with Adrenaline (Aspen Pharma Trading Ltd, Dentsply Ltd) | On Formulary | ||||
Note:
Hospital only |
|||||
lidocaine with cetrimide | Off Formulary | ||||
lidocaine with phenylephrine | On Formulary | ||||
Lidocaine with phenylephrine
Hospital Use Only |
|||||
Spray | |||||
Lidocaine with phenylephrine (Non-proprietary) | On Formulary | ||||
lidocaine with prilocaine | On Formulary | ||||
mepivacaine hydrochloride | On Formulary | ||||
MEPIVACAINE HYDROCHLORIDE
Hospital Use Only |
|||||
Solution for injection | |||||
Scandonest plain (Septodont Ltd) | On Formulary | ||||
Scandonest® 3% Plain
Hospital Use Only |
|||||
mepivacaine with adrenaline | Off Formulary | ||||
prilocaine hydrochloride | Off Formulary | ||||
PRILOCAINE HYDROCHLORIDE
Hospital Use Only |
|||||
prilocaine with felypressin | Off Formulary | ||||
ropivacaine hydrochloride | Hospital Only | ||||
Ropivacaine
Hospital Use Only |
|||||
Solution for injection | |||||
Ropivacaine hydrochloride (Non-proprietary) | Hospital Only | ||||
Ropivacaine
Hospital Use Only |
|||||
Infusion | |||||
Ropivacaine hydrochloride (Non-proprietary) | Hospital Only | ||||
Ropivacaine
Hospital Use Only |
|||||
tetracaine | On Formulary | ||||
Topical anaesthetic
Over 1 month of age: 1st line - lidocaine 4% cream - LMX4 2nd line - tetracaine 4% - Ametop
|
|||||
Eye drops | |||||
Tetracaine (Non-proprietary) | On Formulary | ||||
Nervous system / Alcohol dependence | |||||
carbamazepine | Off Formulary | ||||
Modified-release tablet | |||||
Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | Off Formulary | ||||
Oral suspension | |||||
Carbamazepine (Non-proprietary) | Off Formulary | ||||
Tegretol (Novartis Pharmaceuticals UK Ltd) | Off Formulary | ||||
Suppository | |||||
Carbamazepine (Non-proprietary) | Off Formulary | ||||
diazepam | Off Formulary | ||||
Diazepam
Injection formulation is Hospital Only |
|||||
Nervous system / Nicotine dependence | |||||
nicotine | On Formulary | ||||
Sublingual tablet | |||||
Nicotine (Non-proprietary) | On Formulary | ||||
Nicorette Microtab (McNeil Products Ltd) | On Formulary | ||||
Medicated chewing-gum | |||||
Nicotine (Non-proprietary) | On Formulary | ||||
Nicorette (McNeil Products Ltd) | On Formulary | ||||
Transdermal patch | |||||
Nicotine (Non-proprietary) | On Formulary | ||||
Nicorette invisi (McNeil Products Ltd) | On Formulary | ||||
Spray | |||||
Nicotine (Non-proprietary) | On Formulary | ||||
Nicorette (McNeil Products Ltd) | On Formulary | ||||
Nicorette QuickMist (McNeil Products Ltd) | On Formulary | ||||
Nervous system / Opioid dependence | |||||
buprenorphine | Off Formulary | ||||
PCA NCA Policy Link
see attached |
|||||
methadone hydrochloride | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Oral solution | |||||
Methadone hydrochloride (Non-proprietary) | On Formulary | ||||
Metharose (Rosemont Pharmaceuticals Ltd) | On Formulary | ||||
Physeptone (Martindale Pharmaceuticals Ltd) | On Formulary | ||||
Nervous system / Psychoses and schizophrenia | |||||
amisulpride | On Formulary | ||||
aripiprazole | On Formulary |
NICE TA213 NICE TA292 |
|||
Orodispersible tablet | |||||
Aripiprazole (Non-proprietary) | On Formulary | ||||
Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) | On Formulary | ||||
Oral solution | |||||
Aripiprazole (Non-proprietary) | On Formulary | ||||
Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) | On Formulary | ||||
chlorpromazine hydrochloride | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH
see attached |
|||||
Oral solution | |||||
Chlorpromazine hydrochloride (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
clozapine | On Formulary | ||||
CLOZAPINE
Hospital use only |
|||||
haloperidol | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Oral solution | |||||
Haloperidol (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
olanzapine | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Orodispersible tablet | |||||
Olanzapine (Non-proprietary) | On Formulary | ||||
pericyazine | Off Formulary | ||||
risperidone | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Orodispersible tablet | |||||
Risperidone (Non-proprietary) | On Formulary | ||||
Oral solution | |||||
Risperidone (Non-proprietary) | On Formulary | ||||
sulpiride | On Formulary | ||||
trifluoperazine | On Formulary | ||||
Oral solution | |||||
Trifluoperazine (Non-proprietary) | On Formulary | ||||
Nervous system / Bipolar disorder and mania | |||||
aripiprazole | On Formulary |
NICE TA213 NICE TA292 |
|||
Orodispersible tablet | |||||
Aripiprazole (Non-proprietary) | On Formulary | ||||
Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) | On Formulary | ||||
Oral solution | |||||
Aripiprazole (Non-proprietary) | On Formulary | ||||
Abilify (Otsuka Pharmaceuticals (U.K.) Ltd) | On Formulary | ||||
carbamazepine | On Formulary | ||||
Antiepileptic Adjustment Chart
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Modified-release tablet | |||||
Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
Oral suspension | |||||
Carbamazepine (Non-proprietary) | On Formulary | ||||
Tegretol (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Suppository | |||||
Carbamazepine (Non-proprietary) | On Formulary | ||||
chlorpromazine hydrochloride | On Formulary | ||||
Oral solution | |||||
Chlorpromazine hydrochloride (Non-proprietary) | On Formulary | ||||
haloperidol | On Formulary | ||||
Oral solution | |||||
Haloperidol (Non-proprietary) | On Formulary | ||||
lamotrigine | Off Formulary | ||||
lithium carbonate | On Formulary | ||||
Modified-release tablet | |||||
Camcolit (Essential Pharma Ltd) | On Formulary | ||||
lithium citrate | On Formulary | ||||
Oral solution | |||||
Priadel (Essential Pharma Ltd) | On Formulary | ||||
olanzapine | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Orodispersible tablet | |||||
Olanzapine (Non-proprietary) | On Formulary | ||||
sodium valproate | On Formulary | ||||
Management of Infantile Spasms and West Syndrome
Management of Infantile Spasms and West Syndrome June 2016 |
|||||
Antiepileptic Adjustment Chart
Antiepileptic Adjustment Chart |
|||||
Modified-release tablet | |||||
Epilim Chrono (Sanofi) | On Formulary | ||||
Epival CR (G.L. Pharma UK Ltd) | On Formulary | ||||
Gastro-resistant tablet | |||||
Sodium valproate (Non-proprietary) | On Formulary | ||||
Epilim (Sanofi) | On Formulary | ||||
Modified-release capsule | |||||
Episenta (Desitin Pharma Ltd) | On Formulary | ||||
Modified-release granules | |||||
Epilim Chronosphere MR (Sanofi) | On Formulary | ||||
Episenta (Desitin Pharma Ltd) | On Formulary | ||||
Oral solution | |||||
Sodium valproate (Non-proprietary) | On Formulary | ||||
Epilim (Sanofi) | On Formulary | ||||
Solution for injection | |||||
Sodium valproate (Non-proprietary) | On Formulary | ||||
Powder and solvent for solution for injection | |||||
Sodium valproate (Non-proprietary) | On Formulary | ||||
valproic acid | On Formulary | ||||
Nervous system / Anxiety | |||||
diazepam | Off Formulary | ||||
Diazepam
Injection formulation is Hospital Only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
lorazepam | Hospital Only | ||||
pericyazine | Off Formulary | ||||
trifluoperazine | On Formulary | ||||
Oral solution | |||||
Trifluoperazine (Non-proprietary) | On Formulary | ||||
Nervous system / Depression | |||||
amitriptyline hydrochloride | Off Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Barts Health Guidelines for Treating Acute Pain in Paediatric Patients
See attached |
|||||
Oral solution | |||||
Amitriptyline hydrochloride (Non-proprietary) | On Formulary | ||||
citalopram | On Formulary | ||||
Oral drops | |||||
Citalopram (Non-proprietary) | On Formulary | ||||
doxepin | On Formulary | ||||
fluoxetine | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Oral solution | |||||
Fluoxetine (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
fluvoxamine maleate | On Formulary | ||||
imipramine hydrochloride | On Formulary | ||||
Oral solution | |||||
Imipramine hydrochloride (Non-proprietary) | On Formulary | ||||
lithium carbonate | On Formulary | ||||
Modified-release tablet | |||||
Camcolit (Essential Pharma Ltd) | On Formulary | ||||
lithium citrate | On Formulary | ||||
Oral solution | |||||
Priadel (Essential Pharma Ltd) | On Formulary | ||||
nortriptyline | On Formulary | ||||
sertraline | On Formulary | ||||
Nervous system / Attention deficit hyperactivity disorder | |||||
atomoxetine | On Formulary | ||||
NICE TA: Attention deficit hyperactivity disorder: diagnosis and management
Methylphenidate, atomoxetine and dexamfetamine are recommended, within their licensed indications, as options for the management of ADHD in children and adolescents. |
|||||
dexamfetamine sulfate | On Formulary | ||||
Modified-release capsule | |||||
Dexamfetamine sulfate (Non-proprietary) | On Formulary | ||||
Dexedrine Spansules (Imported (United States)) | On Formulary | ||||
Oral solution | |||||
Dexamfetamine sulfate (Non-proprietary) | On Formulary | ||||
methylphenidate hydrochloride | On Formulary | ||||
Modified-release tablet | |||||
Concerta XL (Janssen-Cilag Ltd) | On Formulary | ||||
Modified-release capsule | |||||
Equasym XL (Takeda UK Ltd) | On Formulary | ||||
Medikinet XL (Medice UK Ltd) | On Formulary | ||||
Nervous system / General anaesthesia | |||||
desflurane | Hospital Only | ||||
DESFLURANE
Hospital Use Only |
|||||
etomidate | Hospital Only | ||||
Solution for injection | |||||
Hypnomidate (Piramal Critical Care Ltd) | On Formulary | ||||
Hypnomidate®
Hospital Use Only |
|||||
Emulsion for injection | |||||
Etomidate (Non-proprietary) | Hospital Only | ||||
Etomidate-Lipuro®
Hospital Use Only |
|||||
isoflurane | On Formulary | ||||
ISOFLURANE
Hospital Use Only |
|||||
nitrous oxide | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
NITROUS OXIDE
Hospital Use Only |
|||||
propofol | On Formulary | ||||
PROPOFOL
Hospital Use Only |
|||||
Emulsion for injection | |||||
Propofol (Non-proprietary) | On Formulary | ||||
Propofol
Hospital Use Only |
|||||
sevoflurane | On Formulary | ||||
SEVOFLURANE
Hospital Use Only |
|||||
thiopental sodium | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH
|
|||||
THIOPENTAL SODIUM
Hospital Use Only |
|||||
Powder for solution for injection | |||||
Thiopental sodium (Non-proprietary) | On Formulary | ||||
Thiopental
Hospital Use Only |
|||||
Nervous system / CNS and respiratory depression | |||||
naloxone hydrochloride | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
NALOXONE HYDROCHLORIDE
Hospital Use Only |
|||||
Barts Health Guidelines for Treating Acute Pain in Paediatric Patients
see attached |
|||||
Bart's Health Clinical Practice Policy for Intravenous PCA/NCA for Paediatric Patients in Acute Pain
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attcahed |
|||||
Solution for injection | |||||
Naloxone hydrochloride (Non-proprietary) | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
Naloxone
Hospital Use Only |
|||||
Barts Health Guidelines for Treating Acute Pain in Paediatric Patients
see attached |
|||||
Nervous system / Reversal of benzodiazepines | |||||
flumazenil | On Formulary | ||||
FLUMAZENIL
Hospital Use Only |
|||||
Solution for injection | |||||
Flumazenil (Non-proprietary) | On Formulary | ||||
Flumazenil
Hospital Use Only |
|||||
Nervous system / Malignant hyperthermia | |||||
dantrolene sodium | On Formulary | ||||
Dantrium Intravenous:
Hospital Use Only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Powder for solution for injection | |||||
Dantrium (Forum Health Products Ltd) | Hospital Only | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
Dantrium Intravenous®
Hospital Use Only |
|||||
Nervous system / Anaesthesia adjuvants | |||||
atropine sulfate | On Formulary | ||||
NEONATAL FORMULARY VERSION 8 2015 BARTS HEALTH
see attached |
|||||
glycopyrronium bromide | Hospital Only | ||||
Difficult to Obtain Letter
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH |
|||||
GLYCOPYRRONIUM BROMIDE
Injection Formulation is Hospital Use Only Oral liquid Glycopyrronium bromide 400microg/mL (Sialanar) for use in sialorrhea. Beware of how concentration is expressed. The bromide salt content (400microg) should be used to calculate dosing. |
|||||
Solution for injection | |||||
Glycopyrronium bromide (Non-proprietary) | On Formulary | ||||
Glycopyrronium bromide
Injection Formulation is Hospital Use Only |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Nervous system / Peri-operative sedation | |||||
alimemazine tartrate | On Formulary | ||||
Oral solution | |||||
Alimemazine tartrate (Non-proprietary) | On Formulary | ||||
diazepam | On Formulary | ||||
Diazepam
Injection formulation is Hospital Only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
see attached |
|||||
ketamine | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Barts Health Guidelines for Treating Acute Pain in Paediatric Patients
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
Paediatric Premedication Guideline
|
|||||
KETAMINE
Hospital Use Only |
|||||
Solution for injection | |||||
Ketalar (Pfizer Ltd) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
Barts Health Guidelines for Treating Acute Pain in Paediatric Patients
|
|||||
Paediatric Premedication Guideline
|
|||||
Ketalar®
Hospital Use Only |
|||||
lorazepam | Hospital Only | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
LORAZEPAM
Injection Formulation is Hospital Use Only |
|||||
midazolam | On Formulary | ||||
NEONATAL FORMULARY VERSION 10
See attached |
|||||
Paediatric Premedication Guideline
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Buccal midazolam
For buccal midazolam doses less than 2.5mg Buccolam pre filled syringes cannot be used; use midazolam oromucosal solution 10mg/ml 4 dose pack (ie 5ml Bottle with 4 syringes pack; Epistatus brand; Unlicensed medicine) For all other doses Bucccolam (licensed) should be used |
|||||
oral midazolam solution
Oral Midazolam liquid is switching to 5mg/mL (Miprosed) This is for the ORAL SOLUTION only for use in oral sedation (not for buccal use) This product (a 7.5mL bottle) is for single use only and hence needs to be discarded after each use. |
|||||
Oral solution | |||||
Midazolam (Non-proprietary) | On Formulary | ||||
Midazolam Shared Care Guideline
see attached |
|||||
Miprosed (Syri Ltd) | Hospital Only | ||||
Ozalin (Primex Pharmaceuticals Oy) | Off Formulary | ||||
Solution for injection | |||||
Midazolam (Non-proprietary) | On Formulary | ||||
Midazolam
Injection Formulation is Hospital Use Only |
|||||
propofol | On Formulary | ||||
PROPOFOL
Hospital Use Only |
|||||
Emulsion for injection | |||||
Propofol (Non-proprietary) | On Formulary | ||||
Propofol
Hospital Use Only |
|||||
remifentanil | On Formulary | ||||
REMIFENTANIL
Hospital Use Only |
|||||
Powder for solution for injection | |||||
Remifentanil (Non-proprietary) | On Formulary | ||||
REMIFENTANIL
Hospital Use Only |
|||||
temazepam | On Formulary | ||||
Paediatric Premedication Guideline
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Oral solution | |||||
Temazepam (Non-proprietary) | On Formulary | ||||
Paediatric Premedication Guideline
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Nervous system / Neuromuscular blockade reversal | |||||
neostigmine | On Formulary | ||||
NEOSTIGMINE
Injection Formulation is Hospital Only |
|||||
NEONATAL FORMULARY BARTS HEALTH
Neonatal Formulary Barts Health |
|||||
NEOSTIGMINE METILSULFATE
Hospital Use Only |
|||||
Solution for injection | |||||
Neostigmine (Non-proprietary) | Hospital Only | ||||
Injection
Hospital Only Drug |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
Neonatal Formulary Version 9 2016 Barts Health |
|||||
NEOSTIGMINE METILSULFATE
Hospital Use Only |
|||||
neostigmine with glycopyrronium bromide | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary -2017
The Association of Paediatric Palliative Medicine Formulary -2017 |
|||||
NEOSTIGMINE WITH GLYCOPYRRONIUM
Hospital Use Only |
|||||
Glycopyrronium-Neostigmine
Hospital Use Only |
|||||
Solution for injection | |||||
Neostigmine with glycopyrronium bromide (Non-proprietary) | On Formulary | ||||
NEOSTIGMINE WITH GLYCOPYRRONIUM
Hospital Use Only |
|||||
Glycopyrronium-Neostigmine
Hospital Use Only |
|||||
sugammadex | On Formulary | ||||
SUGAMMADEX
Hospital Use Only |
|||||
Solution for injection | |||||
Bridion (Merck Sharp & Dohme (UK) Ltd) | On Formulary | ||||
Bridion®
Hospital Use Only |
|||||
Nervous system / Neuromuscular blockade | |||||
atracurium besilate | Hospital Only | ||||
ATRACURIUM BESILATE
Hospital Use Only |
|||||
National supply shortage of neuromuscular blocking agents (NMBAs).
The trust has received notification from the Department of Health & Social Care regarding a national supply shortage of neuromuscular blocking agents (NMBAs). There is no timeline as to when the shortage will be resolved, it is however, anticipated to continue for some time. Please see the memo attached for further information for this drug shortage. |
|||||
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
see attached |
|||||
Atracurium IV monograph for NICU June 2022
Atracurium IV monograph for NICU June 2022 |
|||||
Solution for injection | |||||
Atracurium besilate (Non-proprietary) | Hospital Only | ||||
Atracurium
Hospital Use Only |
|||||
cisatracurium | Off Formulary | ||||
Solution for injection | |||||
Cisatracurium (Non-proprietary) | Off Formulary | ||||
mivacurium | On Formulary | ||||
MIVACURIUM
Hospital Use Only |
|||||
pancuronium bromide | On Formulary | ||||
PANCURONIUM BROMIDE
Hospital Use Only |
|||||
rocuronium bromide | On Formulary | ||||
ROCURONIUM BROMIDE
Hospital Use Only |
|||||
National supply shortage of neuromuscular blocking agents (NMBAs).
The trust has received notification from the Department of Health & Social Care regarding a national supply shortage of neuromuscular blocking agents (NMBAs). There is no timeline as to when the shortage will be resolved, it is however, anticipated to continue for some time. Please see the memo attached for further information for this drug shortage. |
|||||
Solution for injection | |||||
Rocuronium bromide (Non-proprietary) | On Formulary | ||||
Rocuronium
Hospital Use Only |
|||||
Esmeron (Merck Sharp & Dohme (UK) Ltd) | On Formulary | ||||
Esmeron®
Hospital Use Only |
|||||
suxamethonium chloride | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
SUXAMETHONIUM CHLORIDE
Hospital Use Only |
|||||
Solution for injection | |||||
Suxamethonium chloride (Non-proprietary) | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
Suxamethonium Chloride
Hospital Use Only |
|||||
vecuronium bromide | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
VECURONIUM BROMIDE
Hospital Use Only |
|||||
Nervous system / Peri-operative analgesia | |||||
alfentanil | On Formulary | ||||
ALFENTANIL
Hospital Use Only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Solution for injection | |||||
Alfentanil (Non-proprietary) | Off Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
Alfentanil
Hospital Use Only |
|||||
buprenorphine | Off Formulary | ||||
Sublingual tablet | |||||
Buprenorphine (Non-proprietary) | On Formulary | ||||
diclofenac potassium | Off Formulary | ||||
fentanyl | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
PCA NCA Policy Link
|
|||||
FENTANYL
Hospital Use Only |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
See attached |
|||||
Acute pain relief in sickle cell pain crisis (April 2021)
The committee have approved sublingual Fentanyl for acute pain relief in sickle cell pain crisis in paediatric patients of age 14 years and above. |
|||||
Solution for injection | |||||
Fentanyl (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
Fentanyl
Hospital Use Only |
|||||
Solution for infusion | |||||
Fentanyl (Non-proprietary) | On Formulary | ||||
flurbiprofen | Off Formulary | ||||
ibuprofen | On Formulary | ||||
ketorolac trometamol | On Formulary | ||||
KETOROLAC TROMETAMOL
Injection Formulation is Hospital Use Only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Solution for injection | |||||
Ketorolac trometamol (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Ketorolac
Injection Formulation is Hospital Use Only |
|||||
oxycodone hydrochloride | Hospital Only | ||||
pethidine hydrochloride | On Formulary | ||||
PCA NCA Policy Link
|
|||||
PETHIDINE HYDROCHLORIDE
Hospital use only |
|||||
Solution for injection | |||||
Pethidine hydrochloride (Non-proprietary) | On Formulary | ||||
PCA NCA Policy Link
see attached |
|||||
Pethidine
Hospital use only |
|||||
remifentanil | On Formulary | ||||
REMIFENTANIL
Hospital Use Only |
|||||
Powder for solution for injection | |||||
Remifentanil (Non-proprietary) | On Formulary | ||||
Nervous system / Pain | |||||
alfentanil | On Formulary | ||||
ALFENTANIL
Hospital Use Only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Solution for injection | |||||
Alfentanil (Non-proprietary) | Off Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
Alfentanil
Hospital Use Only |
|||||
aspirin | Off Formulary | ||||
bupivacaine hydrochloride | Hospital Only | ||||
BUPIVACAINE HYDROCHLORIDE
Hospital Use Only |
|||||
Solution for injection | |||||
Bupivacaine hydrochloride (Non-proprietary) | On Formulary | ||||
BUPIVACAINE HYDROCHLORIDE
Hospital Use Only |
|||||
Infusion | |||||
Bupivacaine hydrochloride (Non-proprietary) | On Formulary | ||||
BUPIVACAINE HYDROCHLORIDE
Hospital Use Only |
|||||
bupivacaine with adrenaline | Hospital Only | ||||
buprenorphine | Off Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Sublingual tablet | |||||
Buprenorphine (Non-proprietary) | On Formulary | ||||
co-codamol | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients June 2015
Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome). |
|||||
codeine phosphate | On Formulary | ||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
Guidance on restricting codeine use in children
https://www.gov.uk/drug-safety-update/codeine-for-cough-and-cold-restricted-use-in-children |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Paediatric Acute Sickle Cell Pain Pathway
See attached |
|||||
Paediatric Acute Pain Pathway
See attached |
|||||
diamorphine hydrochloride | On Formulary | ||||
Prescribing in Palliative Care
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
PCA NCA Guidelines Link
see attached |
|||||
National supply shortage of Diamorphine 5mg and 10mg Injections
The trust has received notification from the Department of Health & Social Care regarding a national supply shortage of Diamorphine 5mg and 10mg Injections. This shortage is anticipated to last until summer 2020. Please see the memo attached for further information for this drug shortage. |
|||||
Intranasal diamorphine - Formulary
See Paediatric acute sickle cell pain guideline |
|||||
Guidelines for treating acute pain in paediatric in-patients
See attached |
|||||
Powder for solution for injection | |||||
Diamorphine hydrochloride (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
PCA NCA Guidelines Link
see attached |
|||||
Diamorphine
Injection Formulation is Hospital Use Only |
|||||
Prescribing in Palliative Care
http://bartshealthintranet/About-Us/CAGs/Cancer/Palliative-care/Index.aspx
|
|||||
National supply shortage of Diamorphine 5mg and 10mg Injections
The trust has received notification from the Department of Health & Social Care regarding a national supply shortage of Diamorphine 5mg and 10mg Injections. This shortage is anticipated to last until summer 2020. Please see the memo attached for further information for this drug shortage. |
|||||
Guidelines for treating acute pain in paediatric in-patients
See attached |
|||||
diclofenac potassium | Off Formulary | ||||
dihydrocodeine tartrate | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Guidelines for use of Dihydrocodeine for paediatric sickle cell pain management
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients
see attached |
|||||
Modified-release tablet | |||||
DHC Continus (Ennogen Healthcare International Ltd) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
dihydrocodeine with paracetamol | On Formulary | ||||
Guidelines for treating acute pain in paediatric in-patients June 2015
Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome). |
|||||
fentanyl | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
PCA NCA Policy Link
|
|||||
FENTANYL
Hospital Use Only |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
See attached |
|||||
Acute pain relief in sickle cell pain crisis (April 2021)
The committee have approved sublingual Fentanyl for acute pain relief in sickle cell pain crisis in paediatric patients of age 14 years and above. |
|||||
Solution for injection | |||||
Fentanyl (Non-proprietary) | On Formulary | ||||
Solution for infusion | |||||
Fentanyl (Non-proprietary) | On Formulary | ||||
Transdermal patch | |||||
Durogesic DTrans (Janssen-Cilag Ltd) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
hydromorphone hydrochloride | Off Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
ibuprofen | On Formulary | ||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain
see attached |
|||||
PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
levobupivacaine | On Formulary | ||||
Solution for injection | |||||
Chirocaine (AbbVie Ltd) | On Formulary | ||||
levomepromazine | Hospital Only | ||||
mefenamic acid | On Formulary | ||||
Oral suspension | |||||
Mefenamic acid (Non-proprietary) | On Formulary | ||||
methadone hydrochloride | Off Formulary | ||||
morphine | On Formulary | ||||
PCA NCA Guidelines Link
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain
|
|||||
Injections
Hospital use only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Modified-release tablet | |||||
MST Continus (Napp Pharmaceuticals Ltd) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients June 2015
Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome). |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY
see attached |
|||||
Modified-release capsule | |||||
MXL (Napp Pharmaceuticals Ltd) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients June 2015
Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome). |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY
see attached |
|||||
Oral solution | |||||
Morphine (Non-proprietary) | On Formulary | ||||
Lloyds Pharmacy Outpatient Prescription Order & Proforma for Morphine Sulphate Oral Solution 10mg/5ml
see attached |
|||||
Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients June 2015
Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome). |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY
see attached |
|||||
Oramorph (Glenwood GmbH) | On Formulary | ||||
Lloyds Pharmacy Outpatient Prescription Order & Proforma for Morphine Sulphate Oral Solution 10mg/5ml
see attached |
|||||
Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients June 2015
Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome). |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY
see attached |
|||||
Solution for injection | |||||
Morphine (Non-proprietary) | On Formulary | ||||
PCA NCA Policy Link
see attached |
|||||
Sickle-Cell-Disease Management in Children
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients June 2015
Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome). |
|||||
PAEDIATRIC ACUTE SICKLE CELL PAIN PATHWAY
see attached |
|||||
Note:
Hospital use only |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
nitrous oxide | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
NITROUS OXIDE
Hospital Use Only |
|||||
oxycodone hydrochloride | On Formulary | ||||
PCA NCA Policy Link
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Modified-release tablet | |||||
OxyContin (Napp Pharmaceuticals Ltd) | On Formulary | ||||
Guidelines for treating acute pain in paediatric in-patients June 2015
Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome). |
|||||
Oral solution | |||||
Oxycodone hydrochloride (Non-proprietary) | On Formulary | ||||
PCA NCA Policy Link
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
OxyNorm (Napp Pharmaceuticals Ltd) | On Formulary | ||||
PCA NCA Policy Link
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Solution for injection | |||||
Oxycodone hydrochloride (Non-proprietary) | On Formulary | ||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
OxyNorm (Napp Pharmaceuticals Ltd) | On Formulary | ||||
PCA NCA Policy Link
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
paracetamol | On Formulary | ||||
Guidelines for treating acute pain in paediatric in-patients June 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain
|
|||||
PARACETAMOL
Infusion 1g/100ml is hospital use only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH
see attached |
|||||
Paracetamol for Patent Ductus Arteriosus (PDA) in neonates
Approved for use in April 2022 DTC. |
|||||
ropivacaine hydrochloride | Off Formulary | ||||
Ropivacaine
Hospital Use Only |
|||||
tramadol hydrochloride | On Formulary | ||||
Guidelines for treating acute pain in paediatric in-patients February 2018
Oxycodone PCA is also approved for acute pain use at RLH. |
|||||
Tramadol Hydrochloride
Injection Formulation is Hospital Use Only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Oral drops | |||||
Tramadol hydrochloride (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients June 2015
Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
|
|||||
Solution for injection | |||||
Tramadol hydrochloride (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Guidelines for treating acute pain in paediatric in-patients June 2015
Oxycodone PCA is also approved for acute pain use at RLH, in particular for EDS (Ehlers Danlos Syndrome).
|
|||||
Tramadol Hydrochloride
Injection Formulation is Hospital Use Only |
|||||
tramadol with paracetamol | Off Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Nervous system / Headache | |||||
clonidine hydrochloride | Off Formulary | ||||
Oral solution | |||||
Clonidine hydrochloride (Non-proprietary) | Off Formulary | ||||
Solution for injection | |||||
Catapres (Glenwood GmbH) | Off Formulary | ||||
pizotifen | On Formulary | ||||
sumatriptan | On Formulary | ||||
verapamil hydrochloride | Off Formulary | ||||
Nervous system / Migraine | |||||
amitriptyline hydrochloride | Off Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Barts Health Guidelines for Treating Acute Pain in Paediatric Patients
See attached |
|||||
Oral solution | |||||
Amitriptyline hydrochloride (Non-proprietary) | On Formulary | ||||
atenolol | On Formulary | ||||
botulinum toxin type A | Off Formulary | ||||
Powder for solution for injection | |||||
Bocouture (Merz Pharma UK Ltd) | Off Formulary | ||||
Botox (AbbVie Ltd) | Off Formulary | ||||
Dysport (Ipsen Ltd) | Off Formulary | ||||
clonidine hydrochloride | Off Formulary | ||||
Oral solution | |||||
Clonidine hydrochloride (Non-proprietary) | Off Formulary | ||||
Solution for injection | |||||
Catapres (Glenwood GmbH) | Off Formulary | ||||
cyclizine | Off Formulary | ||||
Perioperative Prevention of Post Operative Nausea and Vomiting in Paediatric Patients
See attached |
|||||
diclofenac potassium | Off Formulary | ||||
paracetamol with buclizine hydrochloride and codeine phosphate | On Formulary | ||||
pizotifen | On Formulary | ||||
sodium valproate | Off Formulary | ||||
sumatriptan | On Formulary | ||||
Solution for injection | |||||
Sumatriptan (Non-proprietary) | On Formulary | ||||
timolol maleate | Off Formulary | ||||
topiramate | On Formulary | ||||
Management of Infantile Spasms and West Syndrome
see attached |
|||||
Antiepileptic Adjustment Chart
see attached |
|||||
valproic acid | On Formulary | ||||
zolmitriptan | Off Formulary | ||||
Nervous system / Neuropathic pain | |||||
amitriptyline hydrochloride | On Formulary | ||||
Oral solution | |||||
Amitriptyline hydrochloride (Non-proprietary) | On Formulary | ||||
carbamazepine | On Formulary | ||||
Antiepileptic Adjustment Chart
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Modified-release tablet | |||||
Tegretol Retard (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
Oral suspension | |||||
Carbamazepine (Non-proprietary) | On Formulary | ||||
Tegretol (Novartis Pharmaceuticals UK Ltd) | On Formulary | ||||
Suppository | |||||
Carbamazepine (Non-proprietary) | On Formulary | ||||
gabapentin | On Formulary | ||||
nortriptyline | Off Formulary | ||||
oxycodone hydrochloride | Off Formulary | ||||
phenytoin | Off Formulary | ||||
Nervous system / Dementia | |||||
risperidone | Off Formulary | ||||
Nervous system / Nausea and labyrinth disorders | |||||
aprepitant | Hospital Only | ||||
GOSH Supportive care protocol 2018
GOSH Supportive care protocol 2018 |
|||||
chlorpromazine hydrochloride | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH
see attached |
|||||
Oral solution | |||||
Chlorpromazine hydrochloride (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
cinnarizine | On Formulary | ||||
cyclizine | On Formulary | ||||
Perioperative Prevention of Post Operative Nausea and Vomiting in Paediatric Patients
See attached |
|||||
Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
GOSH supportive care protocol
see attached |
|||||
Solution for injection | |||||
Cyclizine (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
domperidone | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
CF Prescribing Pathway Final Version 5 Dec 2015 SCG
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Oral suspension | |||||
Domperidone (Non-proprietary) | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH
see attached |
|||||
droperidol | Off Formulary | ||||
Solution for injection | |||||
Droperidol (Non-proprietary) | Off Formulary | ||||
fosaprepitant | Off Formulary | ||||
Powder for solution for infusion | |||||
Ivemend (Merck Sharp & Dohme (UK) Ltd) | Off Formulary | ||||
granisetron | Off Formulary | ||||
haloperidol | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Oral solution | |||||
Haloperidol (Non-proprietary) | On Formulary | ||||
Solution for injection | |||||
Haloperidol (Non-proprietary) | On Formulary | ||||
Haloperidol
Injection formulation is Hospital Use Only |
|||||
hyoscine hydrobromide | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
|
|||||
HYOSCINE HYDROBROMIDE
Injection for hospital use only |
|||||
Solution for injection | |||||
Hyoscine hydrobromide (Non-proprietary) | On Formulary | ||||
Hyoscine
Hospital Use Only |
|||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
Neonatal Formulary Version 9 2016 Barts Health |
|||||
Transdermal patch | |||||
Scopoderm (Baxter Healthcare Ltd) | On Formulary | ||||
NEONATAL FORMULARY VERSION 9 2016 BARTS HEALTH
see attached |
|||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
levomepromazine | Hospital Only | ||||
LEVOMEPROMAZINE
Hospital use only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Solution for injection | |||||
Levomepromazine (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
LEVOMEPROMAZINE
Hospital use only |
|||||
Nozinan (Neuraxpharm UK Ltd) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
LEVOMEPROMAZINE
Hospital use only |
|||||
lorazepam | Off Formulary | ||||
metoclopramide hydrochloride | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
|
|||||
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Oral solution | |||||
Metoclopramide hydrochloride (Non-proprietary) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Solution for injection | |||||
Metoclopramide hydrochloride (Non-proprietary) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
NEONATAL FORMULARY VERSION 9 2015 BARTS HEALTH
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
nabilone | Off Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
ondansetron | On Formulary | ||||
Perioperative Prevention of Post Operative Nausea Vomiting in Paediatric Patients 2017
See attached |
|||||
Bart's Health Clinical Practice Policy on Intravenous PCA/NCA for Paediatric Patients in Acute Pain
|
|||||
Paediatric Oncology Local Guidelines July 14
|
|||||
ONDANSETRON
Injection for hospital use only |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Orodispersible tablet | |||||
Ondansetron (Non-proprietary) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Oral solution | |||||
Ondansetron (Non-proprietary) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Solution for injection | |||||
Ondansetron (Non-proprietary) | On Formulary | ||||
Paediatric Oncology Local Guidelines July 14
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
prochlorperazine | On Formulary | ||||
Prochlorperazine
Injection Formulation is Hospital use only |
|||||
PROCHLORPERAZINE
Hospital use only |
|||||
Buccal tablet | |||||
Prochlorperazine (Non-proprietary) | On Formulary | ||||
Solution for injection | |||||
Stemetil (Sanofi) | On Formulary | ||||
Prochlorperazine
Injection Formulation is Hospital use only |
|||||
promethazine hydrochloride | On Formulary | ||||
Oral solution | |||||
Phenergan (Sanofi Consumer Healthcare) | On Formulary | ||||
promethazine teoclate | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
trifluoperazine | On Formulary | ||||
Oral solution | |||||
Trifluoperazine (Non-proprietary) | On Formulary | ||||
Nervous system / Insomnia | |||||
chloral hydrate | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary -2017
See attached |
|||||
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
see attached |
|||||
Oral solution | |||||
Chloral hydrate (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
diazepam | Off Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
melatonin | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Modified-release tablet | |||||
Melatonin (Non-proprietary) | On Formulary | ||||
Melatonin Shared Care Guideline
Melatonin Shared Care Guideline 2014 |
|||||
Difficult to Obtain Letter
Difficult to Obtain Letter |
|||||
Circadin (Flynn Pharma Ltd) | On Formulary | ||||
Melatonin Shared Care Guidelines 2014
|
|||||
The Association of Paediatric Palliative Medicine Formulary - 2015
|
|||||
Difficult to Obtain Letter
|
|||||
promethazine hydrochloride | On Formulary | ||||
Oral solution | |||||
Phenergan (Sanofi Consumer Healthcare) | On Formulary | ||||
temazepam | Off Formulary | ||||
Nervous system / Narcolepsy | |||||
dexamfetamine sulfate | Off Formulary | ||||
Modified-release capsule | |||||
Dexamfetamine sulfate (Non-proprietary) | Off Formulary | ||||
Dexedrine Spansules (Imported (United States)) | Off Formulary | ||||
Oral solution | |||||
Dexamfetamine sulfate (Non-proprietary) | Off Formulary | ||||
methylphenidate hydrochloride | Off Formulary | ||||
Nervous system / Dystonias and other involuntary movements | |||||
botulinum toxin type A | Hospital Only | ||||
BOTULINUM TOXIN use in Paediatrics
Hospital use only Treatment of idiopathic constipation Anorectal dysfunction following operations for Hirschsprung’s disease and Anorectal anomolies oesophageal atresias Focal Spasticity in children |
|||||
Powder for solution for injection | |||||
Bocouture (Merz Pharma UK Ltd) | Hospital Only | ||||
Botox (AbbVie Ltd) | Hospital Only | ||||
Botox®
Injection Formulation is Hospital use only |
|||||
Dysport (Ipsen Ltd) | Hospital Only | ||||
Dysport®
Injection Formulation is Hospital use only |
|||||
chlorpromazine hydrochloride | On Formulary | ||||
Oral solution | |||||
Chlorpromazine hydrochloride (Non-proprietary) | On Formulary | ||||
clonidine hydrochloride | On Formulary | ||||
Clonidine use in Paediatrics
Sedation in PICU Weaning sedation after PICU
ADHD is hospital only
|
|||||
Oral solution | |||||
Clonidine hydrochloride (Non-proprietary) | On Formulary | ||||
Solution for injection | |||||
Catapres (Glenwood GmbH) | Hospital Only | ||||
clozapine | On Formulary | ||||
CLOZAPINE
Hospital use only |
|||||
diazepam | On Formulary | ||||
Diazepam
Injection formulation is Hospital Only |
|||||
Sickle-Cell-Disease Management in Children
see attached |
|||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
NEONATAL FORMULARY VERSION 10 2018 BARTS HEALTH
see attached |
|||||
haloperidol | On Formulary | ||||
Oral solution | |||||
Haloperidol (Non-proprietary) | On Formulary | ||||
pericyazine | Off Formulary | ||||
procyclidine hydrochloride | On Formulary | ||||
trihexyphenidyl hydrochloride | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |
|||||
Oral solution | |||||
Trihexyphenidyl hydrochloride (Non-proprietary) | On Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2015
see attached |
|||||
Nervous system / Parkinson's disease | |||||
co-careldopa | On Formulary | ||||
procyclidine hydrochloride | On Formulary | ||||
trihexyphenidyl hydrochloride | Off Formulary | ||||
The Association of Paediatric Palliative Medicine Formulary - 2017
see attached |